LARIMAR
Live / Registered — Registered (as of 14 Feb 2023)
What this means for you
Registered since 14 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88446118
- Registration number
- 6980603
- Mark type
- Stylized text
- Filed
- 24 May 2019
- Published for opposition
- 22 Oct 2019
- Registered
- 14 Feb 2023
- Attorney of record
- Keith Toms, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases
Owner
- LARIMAR THERAPEUTICS, INC., BALA CYNWYD, PA, US
- LARIMAR THERAPEUTICS, INC., BALA CYNWYD, PA, US
- Chondrial Therapeutics Inc., Bala Cynwyd, PA, US
- Chondrial Therapeutics Inc., Bala Cynwyd, PA, US
Prosecution history
- 14 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 07 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jan 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Dec 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Dec 2022 — USE AMENDMENT FILED
- 13 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 13 Dec 2022 — ASSIGNED TO EXAMINER
- 31 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Aug 2022 — SOU EXTENSION 5 GRANTED
- 09 Jun 2022 — SOU EXTENSION 5 FILED
- 29 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 18 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2021 — SOU EXTENSION 4 GRANTED